title: Might the widespread use of statin drugs explain the increase in prevalence of breast carcinoma in situ?
authors.forename: Mark R
authors.initials: MR
authors.lastname: Goldstein
authors.forename: Luca
authors.initials: L
authors.lastname: Mascitelli
authors.forename: Francesca
authors.initials: F
authors.lastname: Pezzetta
mesh_terms: D001943:Breast Neoplasms / Q000139:chemically induced* / Q000453:epidemiology*; D002278:Carcinoma in Situ / Q000139:chemically induced* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors